Strategies in the surgical treatment of gastric cancer;Aktuelle chirurgische therapiestrategien beim magenkarzinom

Verdauungskrankheiten

Volumn 25, Issue 3, 2007, Pages 112-121

  Meyer, H J ^a   Opitz, G J ^a  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

Author keywords

Extent of resection of the stomach; Gastric carcinoma; Lymphadenectomy; Methods of reconstruction; Multimodal treatment

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; ENDOSCOPIC ECHOGRAPHY; HUMAN; LAPAROSCOPY; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; PANCREAS RESECTION; REVIEW; ROUX Y ANASTOMOSIS; SPLENECTOMY; STOMACH CANCER; TOTAL STOMACH RESECTION; TUMOR LOCALIZATION;

EID: 34347391281     PISSN: 0174738X     EISSN: None     Source Type: Journal    
DOI: 10.5414/vdp25112     Document Type: Review

References (34)

1. Bonenkamp J.J., J. Hermans, M. Sasako et al.: Extended lymph-node dissection for gastric cancer. Dutch gastric cancer group. NEJM 340, 908-914 (1999).
2. Bozetti F., E. Marubini, G. Bonfanti: Total versus subtotal gastrectomy. Ann. Surg. 226, 613-620 (1997).
3. Brennan M.F.: Current status of surgery for gastric cancer: a review. Gastric Cancer 8, 64-70 (2005).
4. Cunningham D., W.H. Allum, S.P. Stenning et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. NEJM 355, 11-20 (2006).
5. Cuschieri A., S. Weeden, J. Fielding et al.: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-Operative Group. Br. J. Cancer 79, 1522-1530 (1999).
6. Degiuli M., M. Sasako, A. Ponti et al.: Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br. J. Cancer 90, 1727-1732 (2004).
7. Dicken B.J., D.L. Bigam, C. Cass et al.: Gastric adenocarcinoma. Review and considerations for future directions. Ann. Surg. 241, 27-39 (2005).
8. Feußner H., F. Härtl: Staginglaparoscopy in der Onkologie. Chirurg 77, 971-980 (2006).
9. Gouzi J.L., M. Huguier, P.L. Fagniez et al.: Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann. Surg. 209, 162 (1989).
10. Gretschel S., A. Bembenek, C. Ulmer et al.: Lymphatic mapping and sentinel - Lymphknotendiagnostik beim Magenkarzinom. Chirurg 74, 132-138 (2003).
11. Hartgrink H.H., C.J.H. van de Velde, H. Putter et al.: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J. Clin. Oncol. 32, 2069-2077 (2004).
12. Hermanek P.: Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magenkarzinoms. Leber Magen Darm 26, 64-72 (1996).
13. Huscher C.G.S., A. Mingole, G. Sgarzini et al.: Laparoscopic versus open subtotal gastrectomy for distal gastric cancer. Five-year results of a randomized prospective trial. Ann. Surg. 241, 232-237 (2005).
14. Jakobs R., U. Weickert, J.F. Riemann: Endoskopische Mukosaresektion früher gastrointestinaler Tumoren. Klinikarzt 34, 5-10 (2005).
15. Lee Y.T., E.K.W. Ng, L.C.T. Hung et al.: Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 54, 1541-1545 (2005).
16. Kitagawa Y., M. Burian, M. Kitajimi: Zur Methodik des Sentinel Lymph Node Mapping. Chirurg 75, 751-755 (2004).
17. McCulloch P., E. Niita, H. Kazi et al.: Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br. J. Surg. 92, 5-13 (2005).
18. Maruyama K., M. Sasako, T. Konishita: Pancreas-preserving total gastrectomy for proximal gastric cancer. World J. Surg. 19, 532-536 (1995).
19. Maruyama K., M. Kaminishi, K. Hayashi et al.: Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9, 51-66 (2006).
20. Meyer H.-J., J. Jähne, A. Weimann: Chirurgische Therapie des Magenkarzinoms - Indikation zur Splenektomie. Chirurg 65, 427-440 (1994).
21. Meyer H.-J., H.R. Zachert, J. Jähne: Magenkarzinom: Stellenwert der Lymphknotendissektion. Visceralchirurgie 35, 257-264 (2000).
22. Meyer H.-J., H. Wilke: Aktueller Stand multimodaler Therapiekonzepte beim Magenkarzinom. Viszeralchirurgie 36, 12-19 (2001).
23. Meyer H.-J., G.J. Opitz, H.R. Zachert: Moderne Chirurgie des Magenfrühkarzinoms. Chir. Gastroenterol. 18, 122-127 (2002).
24. Meyer H.-J.: The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. EJSO 31, 595-604 (2005).
25. Meyer H.-J.: Aktuelle chirurgische Therapiemöglichkeiten: Ösophagus- und Magenkarzinom. Onkologie heute 1, 12-16 (2006).
26. Mönig S.P., P.H. Collet, S.E. Baldus et al.: Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J. Surg. Oncol. 76, 89-92 (2001).
27. Mönig S.P., T. Lübke, S.E. Baldus et al.: Primärtherapie des Magenkarzinoms. Onkologe 11, 630-639 (2005).
28. Phan A.T., J.A. Ajani: Gastric carcinoma. Current Oncology Reports 6, 192-198 (2004).
29. Sano T., M. Sasako, S. Yamatomo et al.: Gastric cancer surgery: morbidity and mortality results from a prospective controlled trial comparing D2 and extended para-aortic lymphadenectomy: Japan Clinical Oncology Group Study 9501. J. Clin. Oncol. 14, 2767-2773 (2004).
30. Sasako T., S. Sano, A. Yamamoto et al.: Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: Japan Clinical Oncology Group 9501. J. Clin. Oncol. 24 (Abstract), 4015 (2006).
31. Sendler A., M. Etter, K. Böttcher et al.: Resektionsausmaß in der Chirurgie des Magenkarzinoms. Chirurg 73, 316-324 (2002).
32. Siewert J.R., A.H. Hölscher, K. Becker et al.: Kardiakarzinom: Versuch einer therapeutisch relevanten Klassifikation. Chirurg 58, 25-32 (1987).
33. Siewert J.R., K. Böttcher, H. Stein: Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann. Surg. 228, 449-461 (1998).
34. Siewert J.R.: Auf der Suche nach der individuellen Indikation zur D2-Lymphadenektomie beim Magenkarzinom. Chirurg 75, 1145-1150 (2004).